Results 1 to 10 of about 63,195 (230)

HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY

Alʹmanah Kliničeskoj Mediciny, 2016
Hypertrophic cardiomyopathy (HCMP) is a relatively common disease with genetic predisposition, that is widely spread irrespective of gender, race or ethnicity. The cause of this pathology are mutations of genes encoding synthesis of contracting proteins.
A. G. Osiev, R. A. Naydenov, E. I. Kretov, N. R. Obedinskaya, V. P. Kurbatov   +4 more
doaj   +3 more sources

Hypertrophic obstructive cardiomyopathy [PDF]

Annals of Cardiothoracic Surgery, 2017
Hypertrophic obstructive cardiomyopathy is an inherited myocardial disease defined by cardiac hypertrophy (wall thickness ≥15 mm) that is not explained by abnormal loading conditions, and left ventricular obstruction greater than or equal to 30 mm Hg. Typical symptoms include dyspnoea, chest pain, palpitations, and syncope.
Christopher, Harris, Beth, Croce, Stine, Munkholm-Larsen   +2 more
openaire   +4 more sources

Hypertrophic Obstructive Cardiomyopathy [PDF]

Deutsches Ärzteblatt international, 2019
Hypertrophic cardiomyopathy (HCM) is caused by mutations in a number of genes. Its prevalence is 0.2% to 0.6%.This review is based on publications retrieved by a selective literature search and on the authors' clinical experi- ence.70% of patients with HCM suffer from the obstructive type of the condition, clinically characterized by highly dynamic and
Angelika, Batzner, Hans-Joachim, Schäfers, Konstantin V, Borisov, Hubert, Seggewiß   +3 more
openaire   +3 more sources

Efficacy and safety of mavacamten in treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis

Future Science OA, 2023
Aim: This meta-analysis was performed to assess the efficacy and safety of mavacamten in patients with hypertrophic cardiomyopathy. Methods & materials: A search was conducted using PubMed, Cochrane, and Scopus up to August 2022 for randomized studies ...
Areeba Memon, Muhammad Omar Larik, Zoha Khan, Maryam Urooj, Areeka Irfan, Beena Kumari, Mehak Faisal, Rida Siddiqui, Moniba Tehrim, Ishaque Hameed   +9 more
doaj   +1 more source

Coronary-Cameral Fistula Following Myectomy in Hypertrophic Obstructive Cardiomyopathy. [PDF]

Tex Heart Inst J
Pu A, Annabathula RV, Ananthram MG.
europepmc   +2 more sources

Clinical Efficacy and Safety of Cox-Maze IV Procedure for Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy

Frontiers in Cardiovascular Medicine, 2021
Objective: Atrial fibrillation is the most prevalent persistent arrhythmia in patients with hypertrophic obstructive cardiomyopathy. Comparative analyses of the safety and effectiveness of septal myectomy with and without surgical ablation are limited ...
Yanhai Meng, Yanbo Zhang, Ping Liu, Changsheng Zhu, Tao Lu, Enci Hu, Qiulan Yang, Changrong Nie, Shuiyun Wang   +8 more
doaj   +1 more source

Periprocedural, Short-Term, and Long-Term Outcomes of Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A 20-Year Single-Center Experience

Anatolian Journal of Cardiology, 2022
Background: Alcohol septal ablation is recommended for hypertrophic obstructive cardiomyopathy patients who had refractory symptoms despite optimal medical treatment.
Umut Karabulut, Yeşim Yılmaz Can, Egemen Duygu, Dilay Karabulut, Kudret Keskin, Tuğrul Okay   +5 more
doaj   +1 more source

Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Information on impact of race and ethnicity on use and early outcomes of septal reduction therapies (SRTs) for obstructive hypertrophic obstructive cardiomyopathy are limited.
Sri Harsha Patlolla, Hartzell V. Schaff, Rick A. Nishimura, Mackram F. Eleid, Jeffrey B. Geske, Steve R. Ommen   +5 more
doaj   +1 more source

Unveiling the Hidden Patterns: Multimodality Cardiac Imaging in Takotsubo Cardiomyopathy Diagnosis

Methodist DeBakey Cardiovascular Journal, 2023
Takotsubo cardiomyopathy, also known as stress cardiomyopathy, is a reversible form of cardiomyopathy characterized by reduced ejection fraction with regional wall motion abnormalities, elevated cardiac enzyme levels, and signs of ischemia on ...
Moath Said Alfawara, Mahmoud Al Rifai, Malek Nayfeh, Mohammed A. R. Chamsi-Pasha, Mouaz H. Al-Mallah   +4 more
doaj   +1 more source

Mega Coronary Arteries with Obstructive Coronary Artery Disease in Hypertrophic Obstructive Cardiomyopathy: A Case Report and Literature Review

Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2022
We report a rare case of hypertrophic obstructive cardiomyopathy (HOCM) presenting with mega coronary arteries with obstructive coronary artery disease.
Debasish Das, Debasis Acharya, Tutan Das, Subhas Pramanik   +3 more
doaj   +1 more source